Headed by Gordon Mills and Rehan Akbanie, the MD Anderson GCC will use reverse phase protein arrays to investigate tumor tissue from a variety of NCI projects.
The effort will use Biognosys' HRM method to complement its MALDI-TOF approach to biomarker work, a company official said.
The funds will support a multi-center clinical study investigating the test's usefulness in diagnosing elderly patients with lower respiratory tract infections.
The upgrade follows four consecutive quarters of above-industry-average revenue growth, driven by the biopharma end market, and the addition of a new CEO.
The collaboration is focused on using Biognosys' HRM mass spec technology to facilitate Biodesix's companion diagnostic work.
In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.
A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.
Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.
Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."